DR ANTHONY OLIVA, PhD
- Chief Scientific Officer: American Cell Technology, LLC
- Found & Chief Scientific Officer: Sanaregen Vision Therapeutics, Inc.
Dr. Anthony Oliva is the Chief Scientific Officer of American Cell Technology, LLC, and Founder and Chief Scientific Officer of Sanaregen Vision Therapeutics, Inc. He earned his PhD in Neuroscience from Baylor College of Medicine and his BA from the University of Chicago. Bridging scientific discovery with biotechnology entrepreneurship, Dr. Oliva is a recognized leader in regenerative medicine for healthy aging.
Dr. Oliva’s career spans academic, industry, and advisory roles, where he has led multiple clinical research programs advancing cell therapies for aging‒related indications, and guided biotech and investment groups focused at the intersection of longevity science and regenerative medicine. His scientific record includes more than one hundred peer‒reviewed publications, book chapters, regulatory filings, and conference presentations. As the lead investigator, his work has received competitive grant funding from the National Institutes of Health, the Alzheimer’s Association, and the Maryland Stem Cell Research Fund, and he regularly contributes as a reviewer on grant evaluation panels. With a sustained commitment to scientific rigor and innovation, Dr. Oliva is driven by a vision to extend healthspan and longevity through transformative regenerative medicine.
The Regenerative Revolution SUMMIT is THE annual conference providing practice owners the leading-edge of practice practical application.